Gene therapy applications for fracture-healing
The Journal of Bone and Joint Surgery. American Volume
|March 20, 2008
Summary
Gene therapy offers a promising solution for fracture healing by enabling continuous, localized protein production at the injury site. This approach overcomes challenges associated with traditional biologic therapies, showing great potential for clinical applications.
Area of Science:
- Orthopedics
- Regenerative Medicine
- Molecular Therapy
Background:
- Biologic therapies, including bone morphogenetic proteins (BMPs), are used to enhance fracture healing.
- Sustained and sufficient delivery of therapeutic proteins remains a significant challenge in current treatments.
- Gene therapy presents a novel strategy to address these limitations.
Purpose of the Study:
- To review current gene therapy approaches for promoting fracture healing.
- To discuss the potential clinical applications of gene therapy in orthopedic settings.
- To highlight the advantages of localized, continuous protein production via gene transfer.
Main Methods:
- Review of preclinical studies and animal models investigating gene therapy for fracture healing.
- Analysis of gene transfer techniques and vector systems used in these studies.
- Evaluation of therapeutic protein expression and fracture healing outcomes.
Main Results:
- Gene therapy has shown significant promise in preclinical models for enhancing fracture repair.
- Localized delivery of genetic material leads to sustained production of healing factors at the fracture site.
- This approach overcomes the limitations of exogenous protein delivery methods.
Conclusions:
- Gene therapy is a viable and potent strategy for improving fracture healing.
- Further research and clinical translation are warranted to realize the full potential of gene therapy in orthopedics.
- Continuous, localized protein production via gene therapy represents a paradigm shift in fracture repair treatments.
Related Concept Videos
01:27Fractures: Bone Repair
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the procedure...
01:31Bone Remodeling and Repair
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:11Healing I: Introduction
Healing is the physiological process by which the body restores the integrity and function of damaged tissues following injury. It involves a coordinated interplay of cellular proliferation, extracellular matrix remodeling, and growth factor signaling. The extent and nature of the tissue damage determine whether healing occurs by resolution, regeneration, or replacement.ResolutionResolution represents the most complete form of healing, occurring when the injury is minimal and tissue...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include: